Life
Gilead to buy cancer biotech Tubulis for more than $3 billion
Strategic angle: Gilead is acquiring the German biotech Tubulis, enhancing its oncology pipeline with a significant investment.
editorial-staff 4 days ago
5 articles tagged with "Biotech"
Strategic angle: Gilead is acquiring the German biotech Tubulis, enhancing its oncology pipeline with a significant investment.
Strategic angle: Insights from Alex Zhavoronkov on becoming a productive biotech AI company.
Strategic angle: The drug demonstrates improved skin clearance, marking a significant advancement in lupus treatment.
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
This approval follows previous claims of its potential use in treating autism symptoms.